scholarly journals TP53 codon 72 Polymorphism and bladder cancer risk: a meta-analysis and emphasis on the role of tumor or smoking status

2018 ◽  
Vol 9 (19) ◽  
pp. 3522-3531 ◽  
Author(s):  
Lei Zhang ◽  
Yi Wang ◽  
Zhiqiang Qin ◽  
Ran Li ◽  
Rong Cong ◽  
...  

SpringerPlus ◽  
2014 ◽  
Vol 3 (1) ◽  
pp. 749 ◽  
Author(s):  
Meire Gonçalves ◽  
Sarah Borja ◽  
Jacqueline Cordeiro ◽  
Vera Saddi ◽  
Flávio Ayres ◽  
...  


Lung Cancer ◽  
2009 ◽  
Vol 66 (1) ◽  
pp. 15-21 ◽  
Author(s):  
Yan Li ◽  
Li-Xin Qiu ◽  
Xiao-Kun Shen ◽  
Xiao-Jing Lv ◽  
Xiao-Ping Qian ◽  
...  


2017 ◽  
Vol 32 (1) ◽  
pp. 113-117
Author(s):  
Zhengdong Hong ◽  
Jinxian Wu ◽  
Qiang Li ◽  
Shouhua Zhang ◽  
Zimin Shi

Background Numerous studies have been conducted to evaluate the association between excision repair cross-complementing group 6 (ERCC6) gene polymorphisms and bladder cancer risk, but their findings have been inconsistent. Here we performed a meta-analysis to attempt to clarify this association. Methods Studies were retrieved from the PubMed and China National Knowledge Infrastructure databases up to October 1, 2015, with strict selection and exclusion criteria. A total of 5,032 samples, comprising samples from 2,475 bladder cancer patients and 2,557 controls from 5 studies, were included in the meta-analysis. The odds ratio (OR) with 95% confidence interval (CI) was used to evaluate the strength of the associations. Results Regarding the Met1097Val polymorphism, no significant association with bladder cancer risk was found in any of the genetic models evaluated (Val vs. Met: OR = 1.10, 95% CI, 0.97-1.25; Val/Val vs. Met/Met: OR = 1.23, 95% CI, 0.86-1.75; Val/Val + Val/Met vs. Met/Met: OR = 1.12, 95% CI, 0.96-1.30; Val/Val vs. Met/Met + Val/Met: OR = 0.81, 95% CI, 0.57-1.14). Similarly, as regards the Arg1230Pro polymorphism, we also found no positive results. Conclusions According to the results of our meta-analysis, there is no evidence of a link between the ERCC6 gene polymorphisms and bladder cancer risk. Well-designed further studies, with larger sample sizes and adjustment for confounders such as smoking status, are needed to confirm these conclusions.





Urology ◽  
2011 ◽  
Vol 77 (3) ◽  
pp. 766-767
Author(s):  
Yan-Feng Zou ◽  
Fang Wang ◽  
Xiao-Liang Feng


Nitric Oxide ◽  
2021 ◽  
Author(s):  
Monireh Sadat SeyyedSalehi ◽  
Elham Mohebbi ◽  
Bahareh Sasanfar ◽  
Fatemeh Toorang ◽  
Kazem Zendehdel


2010 ◽  
Vol 197 (2) ◽  
pp. 174-178 ◽  
Author(s):  
Pei Jiang ◽  
Jianxin Liu ◽  
Xiaoxi Zeng ◽  
Wen Li ◽  
Jianxin Tang


Tumor Biology ◽  
2013 ◽  
Vol 35 (2) ◽  
pp. 1473-1480 ◽  
Author(s):  
Qingtong Ma ◽  
Yumei Zhao ◽  
Shoufeng Wang ◽  
Xiaoyan Zhang ◽  
Jinling Zhang ◽  
...  


2014 ◽  
Vol 33 (3) ◽  
pp. 171-181 ◽  
Author(s):  
Yi Wang ◽  
Chui-Ze Kong ◽  
Zhe Zhang ◽  
Chun-Ming Yang ◽  
Jun Li


2012 ◽  
Vol 4 (5) ◽  
pp. 906-912 ◽  
Author(s):  
DANBO FANG ◽  
FUQING TAN ◽  
CHAOJUN WANG ◽  
XUANWEN ZHU ◽  
LIPING XIE


Sign in / Sign up

Export Citation Format

Share Document